Form4insider filings, from the source

Company · CIK 0000073290 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq

BIOMERICA INC · BMRA

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $158k · 5sales $0 · 0net $158k
$10k$10k$100k$100k$1M$1MbuyssalesMar 28Apr 27May 28Jun 28Jul 29Aug 28Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 26, 2026 PForm 4 →Aug 27, 5:26 pm EDTDavid MoatazediDirector10,000$1.60$16,00040,625+32.7%
Aug 26, 2026 PForm 4 →Aug 27, 5:26 pm EDTEric ChinDirector6,250$1.60$10,00038,750+19.2%
Aug 26, 2026 PForm 4 →Aug 27, 5:24 pm EDTAllen BarbieriExecutive Vice Chairman, Director20,000$1.60$32,00073,542+37.4%
Aug 26, 2026 PForm 4 →Aug 27, 5:23 pm EDTZackary S. IraniChief Executive Officer, Director31,250$1.60$50,000242,570+14.8%
Aug 20, 2026 PForm 4 →Aug 27, 5:27 pm EDTM. Huff GaryDirector31,250$1.60$50,00051,250+156% late

Reported at this company — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.